BRAINSTORM CELL THERAPEUTICS INC. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment of $3.20 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment · last filed 2026-03-31
- 2025-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $3.20M.
- 2024-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $3.00M.
- 2023-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $2.76M.
- 2022-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $2.50M.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
|---|---|
| 2025-12-31 | $3.20M 10-K · filed 2026-03-31 |
| 2024-12-31 | $3.00M 10-K · filed 2026-03-31 |
| 2023-12-31 | $2.76M 10-K · filed 2025-03-31 |
| 2022-12-31 | $2.50M 10-K · filed 2024-04-01 |
| 2021-12-31 | $2.21M 10-K · filed 2023-03-30 |
| 2020-12-31 | $1.95M 10-K · filed 2022-03-28 |
| 2019-12-31 | $1.73M 10-K · filed 2021-02-04 |
| 2018-12-31 | $1.57M 10-K · filed 2020-02-18 |
| 2017-12-31 | $1.46M 10-K · filed 2019-04-01 |
| 2016-12-31 | $1.38M 10-K · filed 2018-03-08 |
| 2015-12-31 | $1.30M 10-K · filed 2017-03-29 |
| 2014-12-31 | $1.21M 10-K · filed 2016-03-09 |
| 2013-12-31 | $1.11M 10-K · filed 2015-03-26 |
| 2012-12-31 | $1.01M 10-K · filed 2014-03-27 |
| 2011-12-31 | $852.00K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |